Antiplatelet Therapy in Older Patients Post-Myocardial Infarction

Sr Care Pharm. 2022 Jan 1;37(1):17-23. doi: 10.4140/TCP.n.2022.17.

Abstract

This case study reviews appropriate antiplatelet treatment options for an older patient post-myocardial infarction and stent placement. This case investigates the benefits and risks associated with antiplatelet agents in older people and what patient- and drug-specific factors, such as adverse effects and drug interactions, to consider when choosing treatment.

MeSH terms

  • Aged
  • Humans
  • Myocardial Infarction* / drug therapy
  • Platelet Aggregation Inhibitors* / adverse effects
  • Platelet Aggregation Inhibitors* / therapeutic use

Substances

  • Platelet Aggregation Inhibitors